Samsara Bio Capital, LLC Gossamer Bio, Inc. Transaction History
Samsara Bio Capital, LLC
- $233 Million
- Q2 2025
A detailed history of Samsara Bio Capital, LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 6,130,268 shares of GOSS stock, worth $11.8 Million. This represents 3.24% of its overall portfolio holdings.
Number of Shares
6,130,268
Previous 6,130,268
-0.0%
Holding current value
$11.8 Million
Previous $6.74 Million
11.82%
% of portfolio
3.24%
Previous 3.11%
Shares
4 transactions
Others Institutions Holding GOSS
# of Institutions
137Shares Held
159MCall Options Held
2.79MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$35.4 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$34.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$22 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$13.8 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $181M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...